A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says.

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

The blood test can be used to steer spinal cord patients to treatments that will best serve them, and more quickly get patients with the worst injuries into cutting-edge clinical trials, Azad said.

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, experts said.

By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of ...

Inside this box is a blood test kit called ‘shield,’ which could literally change the course of colorectal cancer screening for millions of people.

Blood tests that can detect 90% of Alzheimer’s cases could revolutionize access to Alzheimer’s treatment, studies say.

The Shield blood test developed by Guardant has been approved by the FDA as a primary screening option for colorectal cancer, providing a more convenient method of screening.

(CNN) — A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found. In comparison, neurologists and ...